Ubs Asset Management Americas Inc Jazz Pharmaceuticals PLC Transaction History
Ubs Asset Management Americas Inc
- $345 Billion
- Q2 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 73,966 shares of JAZZ stock, worth $8.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,966
Previous 241,685
69.4%
Holding current value
$8.09 Million
Previous $29.1 Million
72.88%
% of portfolio
0.0%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding JAZZ
# of Institutions
490Shares Held
57MCall Options Held
155KPut Options Held
152K-
Vanguard Group Inc Valley Forge, PA6.32MShares$692 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.15MShares$672 Million0.02% of portfolio
-
Lsv Asset Management Chicago, IL2.48MShares$271 Million0.58% of portfolio
-
Capital World Investors Los Angeles, CA2.02MShares$221 Million0.04% of portfolio
-
State Street Corp Boston, MA2.02MShares$221 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.86B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...